CV #7(B): Raj Saini Introduced M-132, Lobbied By Big Pharma

Saini is listed many times in connection with the Lobbying Commissioner’s Office. Many of those communications reports are with pharmaceutical companies who are lobbying him.

Saini is a board member for the Canadian International Council. Here are the main founders that is lists. Some of these names should be familiar.

1. Raj Saini’s LPC Profile

A proud resident of Kitchener-Waterloo, Raj Saini has owned and operated an award-winning small business for nearly 20 years. His success as a small business owner comes from his focus on helping people achieve their health goals using evidence-based protocols to enable healing and encourage healthy lifestyles.
.
A committed and active supporter of local organizations, Raj works tirelessly to engage his community in politics and international affairs. He is a proud Rotarian of many years, a board member of the Canadian International Council, Waterloo Region branch and a long-time champion of Liberal values. He is passionate about improving the local economy, creating jobs and promoting the health and well-being of Kitchener Centre’s residents through intelligent, fiscally responsible environmental and health policy.
.
Raj earned his Bachelors of Science in Chemistry from the University of Toronto, and a Bachelors of Science in Pharmacy from Boston’s Northeastern University.

The above is taken directly from his profile. Let’s get into the issues that exist here, and why they are a problem.

2. Saini Co-Owned A Pharmacy

In 2017, Saini pandered in Parliament on the issue of World Pharmacist’s Day. No shocker, given his personal and professional stake in the industry.

KITCHENER — As a pharmacist, Raj Saini says he learned a few things about serving all segments of society. After getting elected to the House of Commons, he wants to keep doing that, but with a larger customer base — about 102,433 people, to be exact.

That’s the most recent census information available for Kitchener Centre, the riding that Liberal MP-elect Saini will represent after winning last Monday’s federal election in his first run at public office.

As the co-owner of the independent Greenbrook Pharmacy, it should come as no surprise that nothing tops Saini’s list of priorities as he heads to Ottawa more than the need for a national pharmacare policy.

Fewer and fewer Canadians have benefits that cover the costs of prescription drugs and those rising out-of-pocket medicine expenses are the missing link in the country’s universal health care coverage, he said.

Raj Saini is a pharmacist, and co-owns one as well. While there is nothing wrong with this (and is admirable) the strange connections shown later are a cause for concern.

In 2019, Saini rehashed the same old Liberal campaign promise for universal drug coverage. In all fairness though, the LPC has been campaigning on it since 1993 and has never delivered on it.

3. Saini Lobbied By GAVI In 2019

Jason Clark, who works for the firm Crestview Strategy, lobbied Saini on March 8, 2018, on behalf of GAVI. GAVI is the Gates-funded Global Alliance for Vaccines and Immunizations. This was after Saini had introduced M-132, and prior to the Committee hearings in Parliament.

4. Other Pharma Lobbying MP Saini

All of these records can be verified by searching Raj Saini’s name in the Office of the Lobbying Commissioner of Canada. This is by no means all of the records, but shows a pretty good indication of who he has been speaking with.

Remember, it’s legal as long as it’s documented.

5. Canadian International Council

canadian.intl.council.1.bylaws
canadian.intl.council.2.certificate.of.continuance
canadian.intl.council.3.change.of.address
canadian.intl.council.4.change.of.directors

About
What makes the CIC unique is our network of 15 branches across seven provinces. This gives us a presence, in local communities, that is unparalleled in Canadian global affairs.
.
Thanks to this presence, Canadians from all walks of life, all ages, political opinions, and professions can discuss and learn about international affairs and contribute their views. In reflecting on the ideas and interests of a broad constituency of Canadians, the CIC demonstrates that our country’s foreign policy is not an esoteric concern of experts but benefits from direct citizen involvement.
.
As thousands of people join in an ongoing series of events and online discussions, the whole is greater than the sum of its parts. The result is a national conversation on our country’s role in the world.
.
We engage our members and the public to join the conversation through three types of activity: they can attend events, read our research and can share their opinions online.

Saini’s profile states that he is a Director at this organization (the Waterloo Branch). However, in searching him on the internal search, it doesn’t appear that he has contributed any publications to the organizations.

It’s interesting though: to be a Director at this group, which is looking for global solutions (on many issues). Saini introduced M-132, which will increase research and distribution of pharmaceuticals both in Canada and abroad. Certainly this is consistent with CIC’s agenda, but hard to tell if it is influencing the motion.

6. MP Saini Introduced M-132 In 2017

For a speech on passing M-132.
The text is below

Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.

Submissions Lodged
hesa.Structural.Genomics.Consortium.submission
hesa.Medicines.Patent.Pool.2018
hesa.Doctors.Without.Borders.2018
hesa.Canadian.Institutes.Of.Health.Research.2018
hesa.Fowke.Keith.University.Manitoba.2018
hesa.University.College.London.drug.prices.2018
hesa.Drugs.For.Neglected.Diseases.Initiative.2018
hesa.Moon.Suerie.2018
hesa.Yusuf.Salim.mcmaster
hesa.FIND.tb.alliance.gates.gavi.unitaid
hesa.Vlassoff.Carol.2018
hesa.Universities.Allied.For.Essential.Medecines.2018
hesa.Bruyere.Research.Institute.2018
hesa.Molyneux.David.2018

Dates Of Meetings
Thursday, September 27, 2018
Hesa.2018.September.27.evidence.transcript

Tuesday, October 2, 2018
Hesa.2018.October.2.evidence.transcript

Thursday, October 4, 2018
Hesa.2018.October.4.evidence.transcript

Tuesday, October 16, 2018
Hesa.2018.October.16.evidence.transcript

Thursday, October 18, 2018
Hesa.2018.October.18th.evidence.transcript

Tuesday, October 23, 2018
Hesa.2018.October.23.evidence.transcript

Thursday, October 25, 2018
Hesa.2018.October.25.evidence.transcript

REPORTS ISSUED
hesa.november.2018.report.to.parliament
hesa.government.response.march.2019

HOW THE FEDERAL GOVERNMENT COULD FOSTER INNOVATION IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN CANADA AND GLOBALLY
.
Witnesses suggested to the Committee that the federal government could address these challenges by increasing its investments in health research; promoting the creation of innovative alternative models of pharmaceutical R&D; and establishing strategic priorities for pharmaceutical R&D in line with both domestic and international population health needs.

(ii) Repurposing of Existing Drugs Dr. Keith Fowke, Professor, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, told the Committee that federal funding of research focusing on examining ways to repurpose existing drugs that are safe, affordable and globally available to treat new conditions is another possible approach of reducing the costs of drug development, while ensuring affordable access to treatments. He explained to the Committee that his CIHR-funded research on HIV/AIDS examined the role that aspirin could play in preventing the spread of infection by reducing inflammation in cells in the genital tract that are susceptible to the HIV virus. His research showed that aspirin reduced the number of HIV target cells in the genital tract by 35%, which is paving the way for clinical trials in this area. Dr. Fowke recommended that CIHR continue to support innovative fundamental research that focuses on the repurposing of existing widely available generic drugs for the treatment of new conditions, an approach that reduces timelines and costs for R&D as these medications already exist

C. Develop a Strategic Framework for Federally Funded Health Research in Canada and Abroad
Finally, the Committee heard from both Drs. Nickerson and Yusuf that the federal government needs to develop a strategic framework that identifies priorities for health research funding that focuses on population health needs both in Canada and abroad. Though various federal government departments and agencies, including CIHR, the Public Health Agency of Canada and Global Affairs Canada have proposed priorities for federal health research funding both nationally and internationally, witnesses indicated that there is a need to review and better coordinate health research priorities across government to determine whether they are meeting population health needs. This priority setting would help identify areas where the federal government should target its investments in pharmaceutical R&D, which would leverage Canadian expertise across governments, universities, industry and civil society.

It cannot be overemphasized that these reports focus not only on cheap drugs for Canadians. They also are directed to the world at large. Presumably they will be sold at low rates, but since it’s not specified, they could be donated. Those are quotes from the November 2018 report that was released.

7. MP Saini Attended MIX Grand Opening

KITCHENER, ON, Jan. 10, 2020 (GLOBE NEWSWIRE) — Medical Innovation Xchange (MIX), Canada’s first industry-led hub for medtech startups, celebrated its official launch and ribbon-cutting ceremony on Friday, January 10, 2020 at its Kitchener headquarters. Mr. Simon Kennedy, Deputy Minister, Innovation, Science & Economic Development provided the keynote address on what infrastructure is required to help retain and successfully scale Canadian medtech startups. Honoured guests included Kitchener Mayor Berry Vrbanovic, Member of Parliament Raj Saini, Member of Parliament Tim Louis, and industry leaders including prominent medtech CEOs, investors, hospital administrators, and government officials.

MIX, spearheaded in June 2019 by Intellijoint Surgical CEO Armen Bakirtzian, joins the powerful community within the Toronto-Waterloo Innovation Corridor to offer Canadian medtech companies an environment to grow locally and go to market globally. MIX Residents have a unique opportunity to retain ownership in early stages and succeed by leveraging MIX resources to avoid early stage pitfalls and post-prototype growing pains. The successes of Intellijoint Surgical, which celebrated its landmark 10,000th surgery in April of last year, and other successful Canadian medtech strategic advisors, help illuminate the path to bootstrapping as an alternative to acquisition by, for example, global medical device and pharmaceutical companies or packing up and moving operations to the United States.

“We are experiencing a tech boom right across our region,” adds Tim Louis, MP for Kitchener Conestoga. “We excel at IP development, and have a global reputation in high-tech manufacturing – from automotive to aerospace. But we understand that more must be done to cultivate local successes. When IP leaves the country, we miss out on future opportunities, as well as the potential spillover effect from high-tech research. MIX will certainly help to address some of those gaps.”

Since the June 2019 announcement of its founding, MIX has already received dozens of inquiries from interested companies seeking to become part of the community. This will ensure Bakirtzian meets his commitment to fill the incubator’s office space with mature startups that would most benefit from peer-to-peer information exchanges over the course of their minimum 18-24 month occupancy. “We are committed to helping ‘grow our own’” says Bakirtzian, “and it starts with ensuring the most promising medtech startups have a home here at 809 Wellington Street where they can thrive and scale.”

MIX, the Medical Innovation Exchange, had it’s grand opening, on January 10, 2020. MP Saini was one of those in attendance. Since its launch, MIX has focused it’s services on the coronavirus epidemic, which happened very shortly afterwards. What a great, but coincidental timing this is. Here is another article covering the launch.

Bakirtzian and MIX’s inaugural Residents want to galvanize these realities for the medtech space and their many peers in the Kitchener-Waterloo area. Their vision also includes addressing tough questions about healthcare procurement policies, which impact the domestic healthcare market, and channels to access more mature sources of funding. They are keenly aware of the immediate and broader impact of their work.

“Canada is a place where innovation thrives – especially here in the Kitchener-Waterloo region.” says Raj Saini, MP for Kitchener Centre. “We offer one of the best economies in the world for new business ventures as well as small and medium enterprises. And medtech is an area rich in intellectual property — something Canadians lead at developing. But we need to improve at commercialization. Of patents filed in the past two years, 60% ended up with global companies within a year.”

“We are experiencing a tech boom right across our region,” adds Tim Louis, MP for Kitchener Conestoga. “We excel at IP development, and have a global reputation in high-tech manufacturing – from automotive to aerospace. But we understand that more must be done to cultivate local successes. When IP leaves the country, we miss out on future opportunities, as well as the potential spillover effect from high-tech research. MIX will certainly help to address some of those gaps.”

MIX, the Medical Innovation Xchange, doesn’t actually do any research itself. Instead, it is a hub, or a place of centralization for others to research. Although this is just starting out, it will be very interesting to see where things lead.

8. Waterloo Corporate Welfare

Today, Raj Saini, Member of Parliament for Kitchener Centre, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for FedDev Ontario, announced a contribution of $2.57 million for Nicoya to scale up operations and accelerate growth into new markets.

“This FedDev Ontario investment in Nicoya is wonderful news for Waterloo Region. Twenty-nine good-paying, highly-skilled jobs will be added in our community, and our thriving biotechnology and health sciences cluster will be strengthened. Our government is committed to ensuring the competitiveness of our region both at home and abroad.”
– Raj Saini, Member of Parliament for Kitchener Centre

Off topic, but Saini handed out $2.57 million to create 29 jobs, or more than $88,000/per job. Great use of taxpayer money.

9. Issue With Saini’s Connection

Raj Saini is a licensed pharmacist, but he has also been lobbied by drug companies (among others) for his entire time in office. One of those parties was GAVI, the Global Vaccine Alliance that is largely financed by Bill Gates and his Foundation. On the surface at least, these look like a clear conflict of interest.

Saini introduced M-132, to get the House of Commons Standing Committee on Health to study ways to increase pharmaceutical research. The people who appeared before the Committee and give submissions have vested interests in seeing this go ahead.

M-132 could be totally coincidental, but consider how it looks. The motion is introduced in 2017, the hearings are in the fall of 2018, and the recommendations are adopted in March 2019. Later that year, Event 201 would be held and the coronavirus “pandemic” would be unleashed.

How convenient it is that the Parliamentary hurdles were cleared in time for drug researching to be advanced.

(1) https://rsaini.liberal.ca/
(2) http://archive.is/dz8Fx
(3) https://www.therecord.com/news-story/6058693-newly-elected-mp-raj-saini-ready-to-give-back-to-kitchener/
(4) http://archive.is/3U1YO
(5) https://openparliament.ca/debates/2017/9/25/raj-saini-1/
(6) http://archive.is/JFfTE
(7) https://thecic.org/about/governance/
(8) http://archive.is/YqLj5
(9) https://www.medicalinnovationxchange.com/
(10) http://archive.is/u3gUp
(11) https://www.globenewswire.com/news-release/2020/01/10/1969154/0/en/Medtech-CEO-Armen-Bakirtzian-paying-it-forward-by-creating-incubator-to-keep-IP-in-Canada-foster-Canadian-talent.html
(12) http://archive.is/TMp6H
(13) https://www.ept.ca/2020/01/tech-incubator-created-to-drive-medical-innovation/
(14) http://archive.is/vNeAz

CV#7: M-132 And International Pharma Research Grants In Canada

1. Other Articles On CV “Planned-emic”

CLICK HERE, for #0: Theresa Tam; archives; articles; lobbying.
CLICK HERE, for #1: piece on Bill Gates, Pirbright, depopulation.
CLICK HERE, for #2: Coronavirus research at U of Saskatchewan.
CLICK HERE, for #3: Gates; WHO, ID2020; GAVI; Vaccines.
CLICK HERE, for #4: Gates using proxies to push vaxx agenda.
CLICK HERE, for #5: Crestview Strategy, GAVI’s lobbying firm.
CLICK HERE, for #6: people GAVI/Crestview lobbied follow Gates.

http://www.lobbycanada.gc.ca

2. HESA Submissions, Evidence, Reports

Submissions Lodged
hesa.Structural.Genomics.Consortium.submission
hesa.Medicines.Patent.Pool.2018
hesa.Doctors.Without.Borders.2018
hesa.Canadian.Institutes.Of.Health.Research.2018
hesa.Fowke.Keith.University.Manitoba.2018
hesa.University.College.London.drug.prices.2018
hesa.Drugs.For.Neglected.Diseases.Initiative.2018
hesa.Moon.Suerie.2018
hesa.Yusuf.Salim.mcmaster
hesa.FIND.tb.alliance.gates.gavi.unitaid
hesa.Vlassoff.Carol.2018
hesa.Universities.Allied.For.Essential.Medecines.2018
hesa.Bruyere.Research.Institute.2018
hesa.Molyneux.David.2018

LINK To Parliamentary Study Main Page

3. Federally Funded Health Research: M-132

For a speech on passing M-132.
The text is below

Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.

4. Parliamentary Committee Meetings

Dates Of Meetings
Thursday, September 27, 2018
Hesa.2018.September.27.evidence.transcript

Tuesday, October 2, 2018
Hesa.2018.October.2.evidence.transcript

Thursday, October 4, 2018
Hesa.2018.October.4.evidence.transcript

Tuesday, October 16, 2018
Hesa.2018.October.16.evidence.transcript

Thursday, October 18, 2018
Hesa.2018.October.18th.evidence.transcript

Tuesday, October 23, 2018
Hesa.2018.October.23.evidence.transcript

Thursday, October 25, 2018
Hesa.2018.October.25.evidence.transcript

5. Reports Released To The Commons

In Canada and around the world, there is rising concern that innovative drugs produced by pharmaceutical companies are no longer affordable and are placing increasing strain on health care budgets. Policy makers have begun to examine ways that public funding for pharmaceutical research and development could address this issue. On 8 November 2017, the House of Commons adopted Private Members’ Business M-132, which requested that the House of Commons Standing Committee on Health (the Committee) “undertake a study on ways of increasing benefits to the public resulting from federally funded research, with the goals of lowering drug costs and increasing access to medicines, both in Canada and globally.”

On 16 and 18 October 2018, the Committee held two meetings as part of this study and heard from a range of witnesses including health researchers, health research funding organizations, patient groups and civil society organizations. Drawing on witness testimony and written submissions, this report examines the role the federal government can play in fostering pharmaceutical research and development both in Canada and globally to ensure that pharmaceutical drugs are accessible and affordable.

Note: Recommendations can be found starting at page 20 in the 2018 report released to the House of Commons.

HOUSE OF COMMONS STANDING COMMITTEE ON HEALTH CALLS ON THE GOVERNMENT OF CANADA TO FOSTER PHARMACEUTICAL RESEARCH AND DEVELOPMENT BOTH IN CANADA AND GLOBALLY THROUGH OPEN SCIENCE
Ottawa, November 26, 2018 –

Bill Casey, Chair of the House of Commons Standing Committee on Health, presented the Committee’s twentieth report today entitled, Towards Open Science: Promoting Innovation in Pharmaceutical Research and Development and Access to Affordable Medications both in Canada and Abroad.

The Committee’s study is in response to Member of Parliament Raj Saini’s Private Members’ Motion M-132, which requested that the Committee, “undertake a study on ways of increasing benefits to the public resulting from federally funded research, with the goals of lowering drug costs and increasing access to medicines, both in Canada and globally.”

In presenting the report to the House, Chair Bill Casey highlighted that “in our testimony, we heard loud and clear that more needs to be done to strengthen research and innovation in Canada. I thank Mr. Saini for bringing forth M-132, and for his efforts in ensuring that the Health Committee can hear why Canada must continue to be a leader in this field.”

Drawing on witness testimony heard over the course of two meetings held on 16 and 18 October 2018 and on 23 written submissions, the Committee’s report examines how increased federal investment in health research, across the continuum from fundamental to clinical research, would support the development of new medicines. However, witnesses also emphasized the importance of ensuring that federal funding in pharmaceutical research and development must also result in the creation of drugs that are affordable in Canada and abroad. Witnesses suggested that this could be achieved by fostering the creation of innovative models of pharmaceutical research that prioritize open science in both the development of new drugs and the repurposing of existing drugs. Witnesses explained that the Government of Canada could lead the way by developing a framework that sets priorities for pharmaceutical research and development and promotes open science through collaboration and leveraging of funding across governments, universities, health charities and private industry.

The Committee agrees with these findings and has included in its report nine recommendations that it believes will support the transformation of pharmaceutical research and development in Canada.

The announcement of the press release is here

Recommendation 1
That the Government of Canada create a specific funding mechanism for the development of clinical trial research and infrastructure in Canada through the Canadian Institutes of Health Research.
.
Recommendation 2
That the Government of Canada increase its funding for clinical trial research and infrastructure in Canada to 10% of the Canadian Institutes of Health Research’s budget to be on par with jurisdictions leading in this area, such as the United Kingdom and the United States.
.
Recommendation 3
That the Government of Canada explore ways to incentivize clinical trial research in Canada for pharmaceutical drugs and incentivize and support the production of those drugs in Canada at an advantaged price for Canada and provide venture capital for the proponent.
.
Recommendation 4
That the Canadian Institutes of Health Research attach a Global Access Licensing requirement to recipients of its research funding that wish to commercialize their research findings.
.
Recommendation 5
That the Canadian Institutes of Health Research include in its existing research and development programs support for the development of open science models of drug discovery.
.
Recommendation 6
That the Canadian Institutes of Health Research develop a framework for open science that supports collaboration and the leveraging of research funding among different partners in pharmaceutical research and development, including health charities, universities, governments, and private industry.
.
Recommendation 7
That Health Canada develop regulatory incentives for pharmaceutical companies that commit to open access to their research data and affordable prices for their products.
.
Recommendation 8
That the Government of Canada undertake a strategic review of its health-related research funding priorities across departments and agencies to enhance coordination, including Health Canada, Public Health Agency of Canada, Canadian Institutes of Health Research, Global Affairs Canada, and Innovation, Science and Economic Development Canada.
.
Recommendation 9
That the Government of Canada explore the feasibility of the public manufacturing of generic medicines.

In the follow-up report, the recommendations were formally adopted.

REPORTS TO PARLIAMENT
hesa.november.2018.report.to.parliament
hesa.government.response.march.2019

6. Committee Members

As provided by the report, these are the names and ranks of the Committee.

STANDING COMMITTEE ON HEALTH

CHAIR

  • Bill Casey

VICE-CHAIRS

  • Marilyn Gladu (lobbied by GAVI)
  • Don Davies
  • MEMBERS

    • Ramez Ayoub
    • Doug Eyolfson
    • Raj Grewal
    • Ben Lobb
    • Ron McKinnon
    • John Oliver (Parliamentary Secretary — Non-Voting Member)
    • Sonia Sidhu
    • Len Webber

    OTHER MEMBERS OF PARLIAMENT WHO PARTICIPATED

    • Randy Boissonnault
    • Terry Duguid
    • Randy Hoback
    • Tom Kmiec
    • Christine Moore
    • Raj Saini (lobbied by GAVI)
    • Dave Van Kesteren

    CLERK OF THE COMMITTEE

    • Marie-Hélène Sauvé

    Why is the list of the Committee Members here? Well, once you see who some of the connections are, it will likely make the report findings a lot more suspicious.

    7. Committee Members & Pharma Lobbying

    The above screenshots came from information provided in the Office of the Lobbying Commissioner of Canada. These are far from exhaustive, but show a snapshot at the lobbying that is going on in Canada. Members of this Parliamentary Committee are being lobbied by various drug companies. It’s not difficult to see that this is done in order to influence them.

    8. Conflict Of Interest Here

    The same committee members who are recommending that Canada undertake more research for pharmaceuticals are the same ones who are being lobbied by pharmaceutical companies. It’s not difficult to piece it together.

    CV #6: Many Bureaucrats GAVI & Crestview Strategy Lobbied Already Followed Gates

    1. Other Articles On CV “Planned-emic”

    CLICK HERE, for #0: Theresa Tam; archives; articles; lobbying.
    CLICK HERE, for #1: piece on Bill Gates, Pirbright, depopulation.
    CLICK HERE, for #2: Coronavirus research at U of Saskatchewan.
    CLICK HERE, for #3: Gates; WHO, ID2020; GAVI; Vaccines.
    CLICK HERE, for #4: Gates using proxies to push vaxx agenda.
    CLICK HERE, for #5: Crestview Strategy, GAVI’s lobbying firm.

    http://www.lobbycanada.gc.ca

    2. GAVI/Crestview Communication Reports

    The following bit was covered in the previous piece. There are 20 communications reports on file over the last two years where Crestview Strategy has lobbied the Federal Government on behalf of GAVI, the Global Vaccine Alliance.

    Dates of Communications Reports
    (1) 2018 March 8
    (2) 2018 March 9
    (3) 2018 March 9
    (4) 2018 October 9
    (5) 2018 October 9
    (6) 2018 October 9
    (7) 2018 October 10
    (8) 2018 October 10
    (9) 2018 October 10
    (10) 2019 June 11
    (11) 2019 June 11
    (12) 2019 June 11
    (13) 2019 June 12
    (14) 2019 June 12
    (15) 2019 June 12
    (16) 2020 January 28
    (17) 2020 January 29
    (18) 2020 January 29
    (19) 2020 January 29
    (20) 2020 January 30

    No, these aren’t duplications. The registry indicates multiple reports on these dates. Here are screenshots of the actual listings.

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented.

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented. While that is likely the case, we need evidence to make that conclusion though.

    The focus of this article will be on the bureaucrats and politicians themselves who are being lobbied. Who are they, what is their game, and is there any conflict of interest? As will be shown below, many of these politicians and bureaucrats may have already been on board prior to meeting with Gates’ proxies.

    It is the next logical step. Crestview Strategy, and their ties to GAVI have been posted, but what about the people they lobbied? What is their take on things?

    3. Sumin Lee, PHAC

    CLICK HERE, for Sumin Lee’s LinkedIn page.
    http://archive.is/L8Gei

    4. Tammy Bell, PHAC

    CLICK HERE, for Tammy Bell’s LinkedIn page.
    http://archive.is/HckL5

    5. Carol Malko, OIAHP

    >

    CLICK HERE, for Carol Malko’s LinkedIn page.
    http://archive.is/z0p1L

    6. Geoffroi Montpetit, Global Affairs

    CLICK HERE, for Geoffroi Montpetit’s LinkedIn page.
    http://archive.is/CL83i

    7. Hanna Button, Global Affairs

    CLICK HERE, for Hanna Button’s LinkedIn page.
    http://archive.is/mu0g5

    8. Sabina Saini, Chief Of Staff, Health Canada

    CLICK HERE, for Sabini Saini’s LinkedIn page.
    http://archive.is/pxGTS

    9. Raj Saini, MP Kitchener Center

    CLICK HERE, for Raj Saini’s Liberal MP website.
    http://archive.is/dz8Fx

    10. Javid Dharas, Special Adviser, PMO

    CLICK HERE, for Javid Dharas’ LinkedIn page.
    http://archive.is/uoJWN

    11. Sean Phelan, Office Of Official Opposition

    CLICK HERE, for Sean Phelan’s LinkedIn page.
    http://archive.is/485te
    Sean’s endorsement letter from Rob Nicholson

    12. Elvanee Veeramalay, Stakeholder Rel., OLO

    CLICK HERE, for Elvanee Veeamalay’s LinkedIn page.
    http://archive.is/tGdVH

    13. Kathleen Davis, Prime Minister’s Office

    CLICK HERE, for Kathleen Davis’ LinkedIn page.
    http://archive.is/l1kQi

    14. Rebecca Caldwell, Director Min. Guilbeault

    CLICK HERE, for Rebecca Caldwell’s LinkedIn page.
    http://archive.is/yZTLQ

    15. Suzanne Taylor, Global Affairs

    CLICK HERE, for Suzanne Taylor’s LinkedIn page.
    http://archive.is/eO4x7

    16. Monique Lugli, CoS, Health Minister

    CLICK HERE, for Monique Lugli’s LinkedIn page.
    http://archive.is/sun1F

    17. Karina Rolland, Office Of Leader Of Opposition

    CLICK HERE, for Karina Rolland’s LinkedIn page.
    http://archive.is/KsPlC

    18. Dara Lithwick, Chief Of Staff, Heritage

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented.
    >CLICK HERE
    , for Dara Lithwick’s LinkedIn page.
    http://archive.is/DhBG0

    19. Yanique Williams, Policy Director, SoW

    CLICK HERE, for Yanique Williams’ LinkedIn page.
    http://archive.is/8AaRl

    20. Did They Already Support Gates?

    Going through the LinkedIn profiles of the bureaucrats whom Crestview Strategy (on behalf of GAVI) have been lobbying, many of them show an interest in Bill Gates, his wife Melinda, or their foundation. It’s worth asking if those profiles have been updated recently to reflect their meetings, or whether they “already” were on board with Gates’ vaccination agenda.

    Would be nice to get an answer on this, but we likely never will. So take the above information for what it’s worth.

    CV #5: Crestview Strategy, The Lobbying Firm Advocating For GAVI’s Vaxx Agenda

    Influence peddling in Canada is more than just a full time job. It requires hiring additional staff, and having additional offices in other cities.

    1. Other Articles On CV “Planned-emic”

    (A) https://canucklaw.ca/cv-0-corona-plandemic-lobbying-deleted-resources-cl-listings-theresa-tam-canadas-hoaxer-zero
    (B) https://canucklaw.ca/cv-1-coronavirus-patent-by-pirbright-institute-funded-by-gates-foundation-climate-change-scam-15/
    (C) https://canucklaw.ca/cv-2-coronavirus-research-at-usask-gates-foundation-undp-funded-ivi-douglas-richardson/
    (D) https://canucklaw.ca/cv-3-bill-gates-vaccines-un-who-gavi-id2020-us-cdc-all-involved/
    (E) https://canucklaw.ca/cv-4-gates-foundation-lobbied-trudeau-using-proxies-into-accepting-vaccine-agenda/

    2. Context For This Piece

    A previous piece address the attempts by GAVI (the Global Vaccine Alliance) to lobby the Federal Government into pushing the vaxx agenda. GAVI used a lobbying firm called Crestview Strategy to do their dirty work

    In going through the profiles of the Crestview Strategy staff, it becomes disturbingly obvious that many of them have political connections. In fact, many of them were involved in recent elections, getting politicians into office.

    So what happens after their candidates gain power? Do they owe favours? Is there any quid pro quo? Or do people go their own way? It seems that the ties run deep. This list doesn’t even include everyone.

    3. Crestview’s Corporate Documents

    Crestview Annual Return (1)
    Crestview Registered office & Directors (3)
    Crestview.Certificate.Of.Amalgamation (2)
    crestview.directors.change.2019

    4. Crestview Lobbied For GAVI/Gates Foundation

    Crestview was lobbying the Federal Government at the end of January, 2020, even as the public is being told that there is nothing to worry about. Interesting.

    The following bit was covered in the previous piece. There are 20 communications reports on file over the last two years where Crestview Strategy has lobbied the Federal Government on behalf of GAVI, the Global Vaccine Alliance.

    Dates of Communications Reports
    (1) 2018 March 8
    (2) 2018 March 9
    (3) 2018 March 9
    (4) 2018 October 9
    (5) 2018 October 9
    (6) 2018 October 9
    (7) 2018 October 10
    (8) 2018 October 10
    (9) 2018 October 10
    (10) 2019 June 11
    (11) 2019 June 11
    (12) 2019 June 11
    (13) 2019 June 12
    (14) 2019 June 12
    (15) 2019 June 12
    (16) 2020 January 28
    (17) 2020 January 29
    (18) 2020 January 29
    (19) 2020 January 29
    (20) 2020 January 30

    No, these aren’t duplications. The registry indicates multiple reports on these dates.

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented.

    Also, going through the profiles of the Crestview Strategy staff, it is troubling to see just how many of them have political connections. While people are allowed to vote and advocate as they please, there comes the serious question of conflicts on interest.

    5. Crestview Lobbyist Ashton Arsenault

    Prior to joining Crestview, Ashton worked as a political aid on Parliament Hill where he was responsible for parliamentary affairs and issues management for the Minister of National Revenue. Prior to that, he worked as a legislative researcher in the Official Opposition Office in Prince Edward Island. He continues to volunteer in electoral politics at the federal level.

    Ashton has been involved in politics for several years, serving as a campaign manager for a Conservative candidate in the 2015 General Election. As well, he served as the University of Prince Edward Island’s Chair of Council from 2011-2012.

    Among other roles, Arsenault helped with the 2015 election campaign of CPC candidate Andy Wang.

    6. Crestview Lobbyist Zakery Blais

    Zakery Blais is a Consultant with Crestview Strategy. With a focus on Canada-U.S. relations and international development, Zakery services clients globally.

    His experience spans both the public and private sectors. He previously worked as a Legislative Assistant to a Canadian Member of Parliament, providing strategic political and communications advice. Prior to joining Crestview Strategy, Zakery also worked in various capacities in public affairs, including as an analyst focused on the energy and natural resources sectors.

    That is from his profile on the Crestview Strategy webpage.

    Fun fact: Blais was an assistant for David Lametti, a former Parliamentary Secretary, and currently the Attorney General of Canada. While Crestview CLAIMS it doesn’t operate on a who-you-know basis, the current lobbyist pushing this is the Attorney General’s former assistant. Not exactly arms length, is it?

    7. Crestview Lobbyist Andrew Brander

    With more than 15 years of experience in federal, provincial and municipal politics, Andrew brings an instinctive understanding of government and media relations, strategic communications and issues management.

    Andrew spent a decade in Ottawa under the Harper Government, during which time he worked for Canada’s Minister of Transport, Minister of Labour and Minister of Natural Resources. On various occasions, he was recognized by his colleagues, appearing in The Hill Times Terrific 25 survey of top parliamentary staffers. During his time in opposition politics, he worked for the Finance Critic and served as Chief of Staff for the Deputy Leader of the Official Opposition. Andrew served as senior staff in the Ford Government, most recently as Director of Communications for The Honourable Rod Phillips, currently Ontario’s Finance Minister.

    Brander spent a decade in Harper’s Government, and has also been in the Ontario Provincial Government.

    8. Crestview Lobbyist Melissa Caouette

    Melissa worked previously for a global law firm as a government affairs and public policy professional and as a Special Assistant to the Premier of Alberta. Melissa has been involved in a number of municipal, provincial and federal campaigns and is active within her community.

    Interesting. She has been an assistant for the Alberta Premier, and has been involved in municipal, provincial and federal elections campaigns.

    9. Crestview Lobbyist Nathan Carr

    Prior to joining Crestview Strategy, Nathan led the digital campaigns practice at a prominent public relations and strategic communications agency in Toronto. As an early adopter of machine-learning in digital advertising, Nathan has helped break new ground in data-driven mobilization for political campaigns and public affairs clients alike. A skilled campaigner, Nathan has led teams to winning outcomes through federal, provincial, and municipal elections.

    Carr was involved in the 2015 Federal election. In fact, he was the President of the High Park Liberal Riding Association.

    10. Crestview Lobbyist Alex Chreston

    Prior to joining the Crestview team, Alex served as a Senior Advisor to Toronto Mayor John Tory focusing on communications and events. He also spent a decade working at Queens Park where he served as a senior aide in the Office of the Leader of the Official Opposition under both John Tory and Tim Hudak.

    Additionally, Alex has worked in strategic planning and execution on campaign teams for multiple provincial and local elections.

    Chreston is yet another lobbyist with political connections. He has ties to the Ontario Conservatives, and to Toronto candidates.

    11. Crestview Lobbyist Jason Clark

    Prior to joining the Crestview Team, Jason has worked in public policy development and advocacy and engagement campaigns, most recently for Engineers Without Borders Canada. Since arriving in Ottawa he has worked work a wide range of Canadian Non-profit organizations on international development and trade issues. Previously, Jason managed one of the largest public engagement campaigns on climate change, energy and sustainability in Great Britain, working in partnership with all levels of government, business, industry and trade associations, the public sector and civil society. Jason has also worked with female entrepreneurs and social enterprises in Lesotho, Africa.

    [Jason Clark] volunteered for several Ottawa-area Liberal Party of Canada candidates during the 2015 election campaign.

    That is from his profile page with Crestview Strategy.

    12. Crestview Lobbyist Hal Danchilla

    Almost every political event in Alberta over the last 30 years has been shaped, advised, managed, directed or informed by Hal Danchilla. He has managed leadership and election campaigns nationally, provincially and locally including as a Chief of Staff and political advisor during the Klein administration, managing the successful underdog campaign of Stephen Mandel to become Mayor of Edmonton, the leadership and national campaign for Stockwell Day and the Canadian Alliance, and most recently a trusted advisor and campaign strategist for Jason Kenney.

    Interesting. It claims that Danchilla is involved in all political affairs in Alberta over the last 3 decades. So when he lobbies it must have considerable clout.

    13. Crestview Lobbyist Jordan Devon

    Prior to joining Crestview, Jordan served as a communications intern in the United Nations office of the World Jewish Congress in Geneva, Switzerland.

    He is an experienced communications professional, having staffed political campaigns at the municipal, provincial, and federal levels, as well as in the office of a Member of Parliament.

    Quite the globalist here. He served as an intern at the United Nations for the office of the World Jewish Congress. Involved in campaigns at the local, provincial and federal levels. Helped get a current MP elected.

    13. Crestview Lobbyist Grant Goldberg

    Grant is a consultant based out of Crestview Strategy’s Toronto office. Prior to joining Crestview Strategy, Grant served as an intern in the United Kingdom where he assisted both the leader of a major political party and an opposition member in the House of Lords. Grant has also worked in international affairs, primarily with a London-based think-tank, and in the field of political risk.

    Grant has been involved in Canadian politics and has worked on campaigns in both his local community and across Ontario.

    Goldberg has been involved in politics for a long time. This is both in the UK, and across Ontario. It seems to be a portable skill.

    14. Crestview Lobbyist Gabriela Gonzalez

    Prior to joining the Crestview team, Gabriela worked at Queen’s Park for four years and is a long-time organizer with the Ontario Liberal Party and the Liberal Party of Canada. Most recently, she worked as a Senior Communications and Operations Advisor to Ontario’s Minister of Economic Development and Growth. Prior to that role, she was the Toronto Regional Advisor at the Liberal Caucus Service Bureau. She also worked for Premier Kathleen Wynne in her role as Minister of Agriculture and Food and Minister Jeff Leal as the Minister of Rural Affairs.

    Gonzalez has extensive connections to both the Ontario Liberals and the Federal Liberals, and has helped out in Cabinet. A true political insider with extensive connections.

    15. Crestview Lobbyist Susie Heath

    Susie Heath is a Senior Consultant at Crestview Strategy based out of the Ottawa Office. Susie brings with her almost a decade of experience in communications, stakeholder engagement, government relations and political campaigns. Prior to joining Crestview, Susie spent a year practicing government relations in Ottawa, and prior to that, over three years in a senior national public affairs role at a global ridesharing company. During this period, she led the communications strategy which resulted in the regulation of ridesharing in communities across Canada.

    Previously, Susie spent over six years at Queen’s Park, where she served as Senior Communications Advisor and Press Secretary to the Minister of Finance, as well as in a number of senior communications and legislative advisor roles to various Ministers.

    She spent 6 years in Queen’s Park, as a Press Secretary for the Minister of Finance, and for other Ministers. Has also spent time in politics in Ottawa. Yet another who goes between provincial and federal politics.

    16. Crestview Lobbyist Matthew John

    Matthew John is Crestview Strategy’s Chief Operating Officer, bringing with him twenty years of experience in government, business strategy and public affairs.

    In a career that has included leadership roles in both the private and public sector, Matthew previously served as Manager of Outreach in the office of Prime Minister Stephen Harper and has held executive positions in political parties at the federal and provincial level.

    John was previously in the Prime Minister’s Office, and has served parties at both the Provincial and Federal level.

    17. Crestview Lobbyist Gail Kelly

    She has been a senior consultant with Crestview Strategy (formerly Canadian Strategy Group) since 2013. Prior to that she spent over six years working in provincial politics with the Progressive Conservative Association of Alberta. Her vast knowledge of the political process and understanding of provincial politics assists her in connecting the needs of clients with the opportunities presented by Government. She has worked with clients from numerous sectors, including not-for-profits, industry associations, corporations, and local businesses, achieving outcomes through strategy development, execution and messaging. Gail holds a BA from McGill University in Economics and Political Science.

    Six years working with the Progress Conservative Association of Alberta. These people cross party lines and seem to be connected to everyone. Not only are a lot of these Crestview employees involved in politics, but many seem to have come from McGill University. A lot of politicians go there too.

    18. Crestview Lobbyist Ella Klein

    Ella was born and raised on Bowen Island and worked as a visitor experience guide at Bowen Island Tourism. Ella coordinated community events and provided support to visitors to the Island. Ella has volunteered on political campaigns at the provincial and federal levels in both British Columbia and Ontario. Ella continues to be involved with local political organizations, participating in canvassing, advocacy activities, and event planning.

    Klein has political ties to both Ontario and BC. In fact, her profile indicates a prolific interest in politics, and now she is in a position to do something about it.

    19. Crestview Lobbyist Joseph Lavoie

    Joseph has more than a decade of campaign and public affairs experience, joining Crestview after years of honing his craft in the United States, Canada and abroad. As a senior political staffer, Joseph served Canada’s former Minister of Foreign Affairs, John Baird before serving former Prime Minister Stephen Harper as his Director of Strategic Communications.

    Lavoie was a staffer for then Cabinet Minister John Baird, and then a staffer for Prime Minister Stephen Harper.

    20. Crestview Lobbyist Madison Leach

    Prior to joining Crestview Strategy, Madison worked as Office Manager and Executive Assistant to Ontario’s Attorney General and Minister of Francophone Affairs where she played a lead role in day to day operations and logistics for the Attorney General and staff, and provided planning support for Ministerial tour.

    Madison has worked in various roles within the Ontario Public Service, including at the Ontario Ministry of Agriculture, Food, and Rural Affairs in policy, program and corporate areas. More recently, Madison provided executive support at the Ministry of the Attorney General to the Chief Administrative Officer and played a key role during the July 2018 government transition, onboarding Attorney General’s office staff and acting as a liaison between the Minister’s office and the Ministry. Madison has also worked for Sodexo as Manager of Operations.

    Leach held various roles including support for the Ontario Attorney General’s Office.

    21. GAVI Lobbying Multiple Parties

    22. Rob Silver, Katie Telford’s Husband

    Liberal strategist and former pundit Rob Silver said Monday he has left the government relations firm he helped create, citing his wife’s position as Justin Trudeau’s chief of staff.

    “Effective Dec. 31, 2015 I am no longer a shareholder or employee of Crestview Strategy,” Silver said in an email Monday afternoon.

    Silver was a partner in the Toronto- and Ottawa-based public affairs agency that, among other things, lobbies the federal government on behalf of clients.

    Rob Silver, husband of Katie Telford, Trudeau’s Chief-of-Staff, helped start up Crestview Strategy, the lobbying firm that GAVI hired to push the vaccine agenda.

    23. Crestview Secures $800M Grant To GAVI

    Trudeau’s Government gave $800 million to GAVI, the Gates funded vaccine alliance. I don’t suppose the Silver-Telford relationship and the incessant lobbying had anything to do with it.

    24. Political Cronies In Lobbying

    There are others, of course. However, the article will stop here, as the point has already been made.

    Political staffers and party figures shouldn’t be in the business of lobbying. Aside from the obvious conflict of interest, it does the public a huge disservice. These influence peddlers should be called out for what they are.

    Keep in mind, the firm of Crestview Strategy has lobbied the Federal Government at least 20 times on behalf of GAVI, the Global Vaccine Alliance that is funded by the Gates Foundation. Gates is using an organization he funds to hire Liberal cronies (Zakery Blais and Jason Clark) to lobby the Liberal Party of Canada.

    I suppose if the Conservatives were in power, Crestview would be using CPC cronies to do the lobbying. After all, they have enough of them on staff.

    CV #4: Gates Foundation Lobbied Trudeau (Using Proxies) Into Accepting Vaccine Agenda

    (Bill Gates predicts no more mass gathering until vaccine developed.

    (See 1:30 mark in this, or original video)

    1. Context For This Article

    Recently, PM Trudeau has echoed Bill Gates’ sentiments that mass vaccination of people is necessary for any sense of normalcy to return. While there has been speculation about this link, there has so far been no proof of collusion between Gates and Trudeau.

    It’s true that there has been collusion. However, Gates did not (directly) lobby the Canadian Government. The used proxies to do this. Specifically, here are the connections:

    (a) The Bill & Melinda Gates Foundation helped found GAVI, the Global Vaccine Alliance in 1999. The foundation donated $750 million at the time, and continues to fund it regularly.

    (b) GAVI sought the services of a lobbying firm called Crestview Strategy. Crestview used 2 of their employees, Jason Clark, and Zakery Blais, for the assignment.

    (c) Clark and Blais have lobbied the Canadian Government on at least 19 occasions since 2018 on various “health” matters, on behalf of GAVI. One more was conducted by Jennifer Babcock, who appears to have left the firm. All of this can be immediately verified by looking up the records in the Office of the Lobbying Commissioner.

    (d) Clark and Blais have connections to the Liberal Party of Canada. Clark volunteered in 2015 for Ottawa area Liberal candidates, and Blais is a former assistant to the (now) Attorney General David Lametti.

    2. GAVI Funded By Gates Foundation

    This is probably the most well known link in the chain. The Bill and Melinda Gates Foundation helped found GAVI, the Global Vaccine Alliance in 1999, and has made regular contributions to it. The foundation essentially runs the show.

    The Global Vaccine Alliance, as the name suggests, is an organization devoted to pushing vaccinations on the public all across the world. Bill Gates has long been a proponent of mass vaccinations.

    3. GAVI Lobbying CDN Gov’t Since 2018

    If you go onto the Lobby Canada website, you can see what lobbyists have been talking to which government officials, who they work for, when they spoke, and what the business was. This is laid out “communications reports”

    Dates of Communications Reports
    (1) 2018 March 8
    (2) 2018 March 9
    (3) 2018 March 9
    (4) 2018 October 9
    (5) 2018 October 9
    (6) 2018 October 9
    (7) 2018 October 10
    (8) 2018 October 10
    (9) 2018 October 10
    (10) 2019 June 11
    (11) 2019 June 11
    (12) 2019 June 11
    (13) 2019 June 12
    (14) 2019 June 12
    (15) 2019 June 12
    (16) 2020 January 28
    (17) 2020 January 29
    (18) 2020 January 29
    (19) 2020 January 29
    (20) 2020 January 30

    No, these aren’t duplications. The registry indicates multiple reports on these dates.

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented.

    4. Crestview Strategy Lobbies For GAVI

    Crestview Annual Return (1)
    Crestview Registered office & Directors (3)
    Crestview.Certificate.Of.Amalgamation (2)
    crestview.directors.change.2019

    Crestview Strategy effectively represents the interests of corporations, not-for-profits and industry associations to achieve results with governments around the world.

    Across Canada and around the world, the rules that govern the government relations industry are changing. The new higher standard that regulates access to information and political contributions have fundamentally changed the public policy dialogue and improved how citizens, companies and associations advocate their interests to elected representatives.

    No longer is a winning outcome based on ‘who you know’ or the ‘magic meeting’. It is about contributing to the policy process, presenting a case that is supported by authentic community voices, verified impact and compelling insight. And getting in front of the right decision makers and opinion leaders to make that case.

    This is in the government relations page of Crestview Strategy. At least they are open about trying to influence governments and public policy.

    5. Crestview Lobbyist Zakery Blais

    Zakery Blais is a Consultant with Crestview Strategy. With a focus on Canada-U.S. relations and international development, Zakery services clients globally.

    His experience spans both the public and private sectors. He previously worked as a Legislative Assistant to a Canadian Member of Parliament, providing strategic political and communications advice. Prior to joining Crestview Strategy, Zakery also worked in various capacities in public affairs, including as an analyst focused on the energy and natural resources sectors.

    That is from his profile on the Crestview Strategy webpage.

    Fun fact: Blais was an assistant for David Lametti, a former Parliamentary Secretary, and currently the Attorney General of Canada. While Crestview CLAIMS it doesn’t operate on a who-you-know basis, the current lobbyist pushing this is the Attorney General’s former assistant. Not exactly arms length, is it?

    6. Crestview Lobbyist Jason Clark

    Prior to joining the Crestview Team, Jason has worked in public policy development and advocacy and engagement campaigns, most recently for Engineers Without Borders Canada. Since arriving in Ottawa he has worked work a wide range of Canadian Non-profit organizations on international development and trade issues. Previously, Jason managed one of the largest public engagement campaigns on climate change, energy and sustainability in Great Britain, working in partnership with all levels of government, business, industry and trade associations, the public sector and civil society. Jason has also worked with female entrepreneurs and social enterprises in Lesotho, Africa.

    [Jason Clark] volunteered for several Ottawa-area Liberal Party of Canada candidates during the 2015 election campaign.

    That is from his profile page with Crestview Strategy.

    7. Rob Silver, Katie Telford’s Husband

    Liberal strategist and former pundit Rob Silver said Monday he has left the government relations firm he helped create, citing his wife’s position as Justin Trudeau’s chief of staff.

    “Effective Dec. 31, 2015 I am no longer a shareholder or employee of Crestview Strategy,” Silver said in an email Monday afternoon.

    Silver was a partner in the Toronto- and Ottawa-based public affairs agency that, among other things, lobbies the federal government on behalf of clients.

    Rob Silver, husband of Katie Telford, Trudeau’s Chief-of-Staff, helped start up Crestview Strategy, the lobbying firm that GAVI hired to push the vaccine agenda. Also, see this $800 million grant from the Canadian taxpayers, instigated by Crestview.

    8. Lobbying Has Netted Results

    Canada is pledging $600 million to the third replenishment of Gavi, the Vaccine Alliance, and committing $47.5 million annually over four years to support the Global Polio Eradication Initiative’s end-game strategy.

    Quick facts
    Gavi, the Vaccine Alliance, is a global health partnership representing stakeholders in immunization from both private and public sectors. Since 2000, Gavi has supported the immunization of 760 million children and saved more than 13 million lives.

    Since 2002, Canada has provided more than $1 billion in funding to Gavi, including $500 million for the current period from 2016 to 2020.

    The Global Polio Eradication Initiative was established in 1988; since then, 2.5 billion children have been vaccinated as a result. The world has never been closer to eradicating polio, but the job is not done. With continued transmission in Afghanistan and Pakistan, we cannot afford to be complacent.

    The funding announced today is part of Canada’s renewed commitment to global health as announced by Prime Minister Justin Trudeau at the Women Deliver Conference in June 2019. The Government of Canada committed to raise its funding to $1.4 billion annually by 2023 to support women’s and girls’ health around the world.

    Let’s keep that pharma money coming, shall we? Canada makes another announcement to keep those pharma dollars rolling in.

    9. Gates Foundation Lobbying Canadian Gov’t

    Neither Bill Gates personally, nor his Foundation may have their name on the efforts to lobby the Canadian Government, but they are behind it. GAVI, the Global Vaccine Alliance, is funded by the Gates Foundation, and they have the same ideological goals.

    GAVI is using Crestview Strategy to lobby on their behalf, and both main lobbyists, Jason Clark and Zakery Blais, have ties to the Liberal Party of Canada. Clark volunteered in 2015 for Ottawa region candidates, and Blais worked for the (current) Attorney General, David Lametti.

    Gates is using GAVI (and LPC operatives-turned-lobbyists) to push the vaccine agenda.

    It doesn’t get much more obvious than this.

    (1) https://canucklaw.ca/mastercard-is-the-final-boss-review/
    (2) https://www.gavi.org/operating-model/gavis-partnership-model/bill-melinda-gates-foundation
    (3) http://archive.is/DHNXn
    (4) https://www.crestviewstrategy.ca
    (5) http://archive.is/aFSsx
    (6) https://www.crestviewstrategy.ca/zakery-blais
    (7) http://archive.is/q3Jzh
    (8) https://www.linkedin.com/in/zakery-blais-13a76b118/
    (9) https://www.crestviewstrategy.ca/jason-clark.
    (10) http://archive.is/nkiou
    (11) https://www.crestviewstrategy.ca/government-relations
    (12) http://archive.is/Vss4p
    (13) https://www.canada.ca/en/global-affairs/news/2020/05/minister-gould-announces-funding-for-global-vaccinations.html

    Ontario’s Bill 168: Doug Ford To Ban Criticism Of Jews Under Guise Of “Anti-Semitism”

    1. Important Links

    (1) bill.168.antisemitism
    (2) https://laws-lois.justice.gc.ca/eng/Const/page-4.html
    (3) https://www.ola.org/en/legislative-business/bills/parliament-42/session-1/bill-168
    (4) http://archive.is/PPk8V
    (5) https://www.holocaustremembrance.com/
    (6) http://archive.is/FMY3i
    (7) https://www.holocaustremembrance.com/resources/working-definitions-charters/working-definition-antisemitism
    (8) http://archive.is/In7MJ

    2. Context For This Article

    Free speech is under attack again, and this time it comes from the Zionists, trying to push their version of anti-Semitism laws. Iqra Khalid was heavily criticized for pushing her Islamophobia motion, M103 a few years ago, but this gets a pass from the media and from public scrutiny. Both are horrible pieces of legislation,

    3. Criminal Law Exclusively Federal

    Under Section 91(27) of the Constitution, criminal law is exclusively the jurisdiction of the Federal Government. This means that the Ford Government couldn’t actually criminalize criticism of Jews, even if they wanted to. Still, it’s pretty chilling to put this on the books in Ontario, even if it is meant to be symbolic.

    This is address the elephant in the room: jurisdiction in the event of potential criminal law changes.

    4. Text Of Bill 168

    Will Bouma and Robin Martin, the sponsors for Bill 168, which was actually a private member’s bill.

    Bill 168 2019
    An Act to combat antisemitism
    Preamble Antisemitism is a multi-faceted problem that requires a multi-faceted strategy, encompassing a range of ministries and agencies. For that reason, it is desirable to require the Government of Ontario to implement a whole-of-government approach in combating antisemitism. As part of that approach, it is desirable to apply a consistent interpretation of Acts, regulations and policies designed to protect Ontarians from discrimination and hate amounting to antisemitism. Therefore, Her Majesty, by and with the advice and consent of the Legislative Assembly of the Province of Ontario, enacts as follows:
    .
    Interpretation
    1 In interpreting Acts, regulations and policies designed to protect Ontarians from discrimination and hate amounting to antisemitism, the Government of Ontario shall be guided by the working definition of antisemitism and the list of illustrative examples of it adopted by the International Holocaust Remembrance Alliance plenary on May 26, 2016. Legislation Act, 2006 amendment
    .
    2 Section 87 of the Legislation Act, 2006 is amended by adding the following definition: “antisemitism” has the meaning set out in the working definition of antisemitism and the list of illustrative examples of it adopted by the International Holocaust Remembrance Alliance plenary on May 26, 2016; (antisémitisme”) Commencement
    .
    3 This Act comes into force on the day it receives Royal Assent. Short title
    .
    4 The short title of this Act is the Combating Antisemitism Act, 2019.
    .
    ______________
    .
    EXPLANATORY NOTE The Bill requires the Government of Ontario to be guided by the working definition of antisemitism and the list of illustrative examples of it, adopted by the International Holocaust Remembrance Alliance plenary on May 26, 2016, when it interprets Acts, regulations and policies designed to protect Ontarians from discrimination and hate amounting to antisemitism. The Bill also amends the Legislation Act, 2006 to adopt that working definition.

    The text is pretty clear. Ontario (if this law passes) is to be guided by the working definition of anti-Semitism as provided by the IHRA. Interestingly, the bill doesn’t say what that definition is. So let’s take a look for ourselves.

    What is it exactly that Ontario will be signing up for?

    5. IHRA Definition Of Anti-Semitism

    On 26 May 2016, the Plenary in Bucharest decided to:
    .
    Adopt the following non-legally binding working definition of antisemitism:
    .
    “Antisemitism is a certain perception of Jews, which may be expressed as hatred toward Jews. Rhetorical and physical manifestations of antisemitism are directed toward Jewish or non-Jewish individuals and/or their property, toward Jewish community institutions and religious facilities.”

    Don’t worry. While this sounds pretty vague, it is about to get much, MUCH more detailed in what exactly counts as anti-Semitism.

    To guide IHRA in its work, the following examples may serve as illustrations:

    Manifestations might include the targeting of the state of Israel, conceived as a Jewish collectivity. However, criticism of Israel similar to that leveled against any other country cannot be regarded as antisemitic. Antisemitism frequently charges Jews with conspiring to harm humanity, and it is often used to blame Jews for “why things go wrong.” It is expressed in speech, writing, visual forms and action, and employs sinister stereotypes and negative character traits.

    Contemporary examples of antisemitism in public life, the media, schools, the workplace, and in the religious sphere could, taking into account the overall context, include, but are not limited to:

    • Calling for, aiding, or justifying the killing or harming of Jews in the name of a radical ideology or an extremist view of religion.
    • Making mendacious, dehumanizing, demonizing, or stereotypical allegations about Jews as such or the power of Jews as collective — such as, especially but not exclusively, the myth about a world Jewish conspiracy or of Jews controlling the media, economy, government or other societal institutions.
    • Accusing Jews as a people of being responsible for real or imagined wrongdoing committed by a single Jewish person or group, or even for acts committed by non-Jews.
    • Denying the fact, scope, mechanisms (e.g. gas chambers) or intentionality of the genocide of the Jewish people at the hands of National Socialist Germany and its supporters and accomplices during World War II (the Holocaust).
    • Accusing the Jews as a people, or Israel as a state, of inventing or exaggerating the Holocaust.
    • Accusing Jewish citizens of being more loyal to Israel, or to the alleged priorities of Jews worldwide, than to the interests of their own nations.
    • Denying the Jewish people their right to self-determination, e.g., by claiming that the existence of a State of Israel is a racist endeavor.
    • Applying double standards by requiring of it a behavior not expected or demanded of any other democratic nation.
    • Using the symbols and images associated with classic antisemitism (e.g., claims of Jews killing Jesus or blood libel) to characterize Israel or Israelis.
    • Drawing comparisons of contemporary Israeli policy to that of the Nazis.
    • Holding Jews collectively responsible for actions of the state of Israel.

    Antisemitic acts are criminal when they are so defined by law (for example, denial of the Holocaust or distribution of antisemitic materials in some countries).
    .
    Criminal acts are antisemitic when the targets of attacks, whether they are people or property – such as buildings, schools, places of worship and cemeteries – are selected because they are, or are perceived to be, Jewish or linked to Jews.
    .
    Antisemitic discrimination is the denial to Jews of opportunities or services available to others and is illegal in many countries.

    Just reading the definition provided, it has to be asked: what DOESN’T make the list? What ISN’T anti-Semitism according to these people?

    When it refers to anti-Semitic acts as criminal, is that in indication that criminalization of “anti-Semitism” is where they intend to go with this?

    6. Status Of Bill 168

    It’s already had its second reading. Not too far to go. Considering Ford has a majority government, he should encounter little resistance in getting Bill 168 passed and signed into law.

    7. CIJA Lobbied For Bill 168

    CIJA, the Center for Israel and Jewish Affairs (the Israeli lobby), is found in the Ontario Lobbyist Registry as attempting to influence the Ford Government to pass Bill 168.

    8. Double Standard For Islamophobia Motion

    A few years back, there was a huge public stink when Iqra Khalid, a Pakistani Muslim and “paper Canadian”, got M-103 passed at the Federal level. This was a (supposedly non binding) motion to combat Islamophobia, but without defining what it actually was.

    Why no media outrage over this? Is it because of the Jewish influence and power in the media that the story is buried? I guess that’s anti-Semitism to ask that.

    Should this ever come to pass, what’s to stop the Feds (or any court) from using it as a precedent to push binding anti-Semitism laws? This is a scary step to take.